Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix.

BACKGROUND We investigated the association between polymorphisms of human papillomavirus (HPV)-33 and squamous intraepithelial lesions (SILs). METHODS Endocervical specimens from 89 women infected with HPV-33, out of a total of 5347 recruited for 2 case-control and 2 cohort studies, were further analyzed by polymerase chain reaction sequencing of the long control region (LCR), E6, and E7. RESULTS Of the 89 samples, 64 were normal, 7 had low-grade SILs (including 3 determined by histopathologic analysis), 15 had high-grade SILs (HSILs, including 14 determined by histopathologic analysis), and 3 had an unknown diagnosis. Non-prototype-like LCR variants were significantly associated with HSILs (age- and study site-adjusted odds ratio [OR], 9.2 [95% confidence interval {CI}, 1.8-45.9]). The C7732G variation, which results in the loss of a putative binding site for the cellular upstream stimulatory factor, was associated with HSILs (age- and site-adjusted OR, 8.0 [95% CI, 1.5-42.8]). E6 and E7 polymorphisms were not associated with HSILs. Samples collected at 6-month intervals from 14 participants contained the same variant. The HPV-33 MT 1-0-0 variant carrying the G7584A variation was detected more frequently in women from Brazil (7/20 [35%]) than in women from Canada (1/65 [1.5%]; P=.001). CONCLUSION Intratypic LCR variants of HPV-33 seem to vary geographically and to differ with respect to their oncogenic potential.

[1]  H. Bernard,et al.  Genome variation of human papillomavirus types: Phylogenetic and medical implications , 2006, International journal of cancer.

[2]  F. X. Bosch,et al.  Worldwide Genomic Diversity of the High-Risk Human Papillomavirus Types 31, 35, 52, and 58, Four Close Relatives of Human Papillomavirus Type 16 , 2005, Journal of Virology.

[3]  E. Franco,et al.  Different P105 promoter activities among natural variants of human papillomavirus type 18. , 2005, The Journal of infectious diseases.

[4]  C. Tremblay,et al.  Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV‐seropositive and HIV‐seronegative women at risk for HIV infection , 2005, Journal of medical virology.

[5]  G. Matlashewski,et al.  The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. , 2005, Cancer detection and prevention.

[6]  C. Tremblay,et al.  Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. , 2004, The Journal of infectious diseases.

[7]  C. Tremblay,et al.  Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women. , 2004, The Journal of infectious diseases.

[8]  Claude Fauquet,et al.  Classification of papillomaviruses. , 2004, Virology.

[9]  H. Bernard,et al.  Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. , 2004, Virology.

[10]  C. Tremblay,et al.  Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women. , 2003, The Journal of infectious diseases.

[11]  S. Franceschi,et al.  Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis , 2003, British Journal of Cancer.

[12]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[13]  C. Wheeler,et al.  Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. , 2003, American journal of obstetrics and gynecology.

[14]  A. Hildesheim,et al.  Host and viral genetics and risk of cervical cancer: a review. , 2002, Virus research.

[15]  P. Chan,et al.  Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. , 2002, The Journal of infectious diseases.

[16]  P. Chan,et al.  Association of human papillomavirus type 58 variant with the risk of cervical cancer. , 2002, Journal of the National Cancer Institute.

[17]  B. Rose,et al.  Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia , 2002, International journal of cancer.

[18]  E. Franco,et al.  Persistent human papillomavirus infection and cervical neoplasia. , 2002, The Lancet. Oncology.

[19]  T. Rohan,et al.  Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. , 2001, JAMA.

[20]  Y. Taketani,et al.  Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. , 2001, Cancer letters.

[21]  B. Rose,et al.  Variable Oncogene Promoter Activity of Human Papillomavirus Type 16 Cervical Cancer Isolates from Australia , 2001, Journal of Clinical Microbiology.

[22]  A. Giannoudis,et al.  Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix , 2001, British Journal of Cancer.

[23]  A. Giannoudis,et al.  Human papillomavirus variants and squamous neoplasia of the cervix , 2001, The Journal of pathology.

[24]  K. Buetow,et al.  Human papillomavirus type 16 variants and risk of cervical cancer. , 2001, Journal of the National Cancer Institute.

[25]  T. Rohan,et al.  Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. , 2000, The Journal of general virology.

[26]  F. Coutlée,et al.  Detection of Human Papillomavirus Type 16 DNA in Consecutive Genital Samples Does Not Always Represent Persistent Infection as Determined by Molecular Variant Analysis , 2000, Journal of Clinical Microbiology.

[27]  C. Wheeler,et al.  Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. , 2000, The Journal of general virology.

[28]  David R. Scott,et al.  Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.

[29]  I. Nindl,et al.  Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra‐epithelial neoplasia and cervical cancer , 1999, International journal of cancer.

[30]  L. Gergely,et al.  Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. , 1999, The Journal of general virology.

[31]  G. Voglino,et al.  Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms , 1998, The Lancet.

[32]  E. Wilander,et al.  Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. , 1998, Cancer research.

[33]  K. Holmes,et al.  Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. , 1997, Journal of the National Cancer Institute.

[34]  C. Wheeler,et al.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective , 1997, Journal of virology.

[35]  C. Desaintes,et al.  Control of papillomavirus DNA replication and transcription. , 1996, Seminars in cancer biology.

[36]  C. Wheeler,et al.  Intratype variation in 12 human papillomavirus types: a worldwide perspective , 1996, Journal of virology.

[37]  Xu-Gang Luo,et al.  Antiproliferative properties of the USF family of helix-loop-helix transcription factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Kiviat,et al.  Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world , 1995, Journal of clinical microbiology.

[39]  F. Stubenrauch,et al.  Prevalence of deletions of YY1‐binding sites in episomal HPV 16 DNA from cervical cancers , 1994, International journal of cancer.

[40]  H. Pfister,et al.  Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups , 1993, Journal of virology.

[41]  N. Kiviat,et al.  The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations , 1993, Journal of virology.

[42]  B. Drescher,et al.  Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind , 1992, Journal of virology.

[43]  T. Nagase,et al.  Binding of the c-myb proto-oncogene product to the simian virus 40 enhancer stimulates transcription. , 1990, The Journal of biological chemistry.

[44]  S. Cole,et al.  Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer , 1986, Journal of virology.